Drug makers defy the advertising slump

Wylot, Robert
November 2001
Warsaw Business Journal;11/5/2001, Vol. 7 Issue 45, p3
Focuses on the pharmaceutical advertising spending of drug manufacturers in Poland. Reason for not reducing the advertising spending; Financial issue concerning advertising expenses; Factors affecting the advertising budget of manufacturers; Rate of advertising budget spent for first three quarters of 2001.


Related Articles

  • HIGH COMPRESSION MARKETING SUPERCHARGES DRUG REVENUES. Loden, D. John; Liebman, Milton // Medical Marketing & Media;Mar2000, Vol. 35 Issue 3, p66 

    Reports that United states pharmaceutical companies, motivated by high research costs and short patent life, utilize `high compression marketing' to drive new drug brand share higher and faster. Success factors for a quick-time blockbuster, as in the case of Celebrex; Includes qualities the...

  • New Media Mix stirs the people. Koberstein, Wayne // Pharmaceutical Executive;Sep97, Vol. 17 Issue 9, p49 

    Talks on the use of direct-to-consumer (DTC) and direct-to-patient (DTP) advertising in the pharmaceutical industry in the United States. Rushing of pharmaceutical companies to create DTC and DTP communications; Speculations on the disadvantage of DTP and DTC; Forces that drive the DTC...

  • Media Mix Town Meeting. Koberstein, Wayne // Pharmaceutical Executive;Sep97, Vol. 17 Issue 9, p50 

    Presents a transcript of the Media Mix Town Meeting in New York sponsored by the magazine `Pharmaceutical Executive,' on how to create an effective direct-to-consumer (DTC) and direct-to-patient (DTP) advertising for the pharmaceutical industry. Communications that augment DTC advertising;...

  • Mixing media and messages. Giddings, Sharon; Madell, Robin // Pharmaceutical Executive;Sep97, Vol. 17 Issue 9, p102 

    Interviews several pharmaceutical company executives on how to effectively use the mass media in the United States. Progress on the industry's use of media; Creation of an effective direct-to-consumer (DTC) and direct-to-patient communications; Industry's use of interactive media like the...

  • MORE ON DRUG COMPANY DECEPTIONS AND ABUSES. Rosch, Paul J. // Health & Stress;2002, Issue 7, p1 

    Reports the advertising deception and abuse issues of drug companies in the U.S. Implications of direct advertising for drug costs and patient pressures; Comparison of funded heart drug on safety and efficacy; Expenditures of drug companies on unethical prescription of products.

  • Direct-to-consumer prescription drug advertising: Trends, impact, and implications. Wilkes, Michael S.; Bell, Robert A. // Health Affairs;Mar/Apr2000, Vol. 19 Issue 2, p110 

    Focuses on the issues concerning direct-to-consumer (DTC) prescription drug advertising in the United States. Factors influencing the emergence of DTC advertising; Overview of DTC drug advertisements; Impact of DTC drug prescribing on patients, doctors and health maintenance organizations;...

  • Promotion of prescription drugs: trade tactics? Medawar, Charles // Consumer Policy Review;Jan/Feb2002, Vol. 12 Issue 1, p18 

    Discusses the tactics used by the pharmaceutical industry to change a European Union rules preventing Direct-To-Consumer-Advertising of prescription drugs. Strategy of the Association of the British Pharmaceutical Industry; Efforts of the European Commission and Member States to improve the...

  • prescription drugs. Bittar, Christine // Adweek Western Edition;04/23/2001, Vol. 51 Issue 17, pSR22 

    Focuses on the advertising efforts of pharmaceutical companies in the United States for 2001. Expected growth in advertising of direct-to-consumer drugs; Budget offered by Merck for the promotion of its Vioxx drug; Top 10 most advertised drugs; Details on the price increase of prescription drugs.

  • THE BIG HEADACHE. Mann, Charles C.; Plummer, Mark L. // Atlantic (02769077);Oct88, Vol. 262 Issue 4, p39 

    Discusses how profits to be made from nearly identical pills have inspired some of America's most creative advertising and some of its longest-running lawsuits. Advertising campaign for Anacin; Illusion that Anacin is substantially different from other aspirin; False advertising brought against...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics